Viyash Scientific Limited (BOM:512529)

India · Delayed Price · Currency is INR

250.15

-6.70 (-2.61%)

At close: May 27, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Pharmaceuticals	34.20B	15.51B	13.70B	14.21B	14.13B
Pharmaceuticals Growth	120.47%	13.26%	-3.60%	0.57%	3.76%
Total	34.20B	15.51B	13.70B	14.21B	14.13B
Total Growth	120.47%	13.26%	-3.60%	0.57%	3.76%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Europe	7.00B	5.72B	5.76B	5.94B
Europe Growth	22.50%	-0.68%	-3.15%	-4.86%
Asia	4.45B	3.30B	4.76B	3.90B
Asia Growth	34.78%	-30.70%	22.16%	0.32%
Rest of the World	4.06B	4.68B	3.69B	4.29B
Rest of the World Growth	-13.20%	26.82%	-13.90%	23.06%
Total	15.51B	13.70B	14.21B	14.13B
Total Growth	13.26%	-3.60%	0.57%	3.76%

Source: S&P Global Market Intelligence.